A critical breakthrough in cancer research is occurring with the use of VHH fragments to reactivate mutated p53. This vital tumor inhibitor protein is frequently disabled in several kinds of tumors, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research